Revenue at PDI falls 28%; Outsourcing improved in 2011, but not so much for manufacturing;

 @NesaNFierce: Clinical and pharma controversy in India hasn't scared off Quanticate. Article | Follow @NesaNFierce

> Outsourcing experienced a recovery in 2011, but contract manufacturing still has a way to go. More

> Revenue fell 28% at PDI, something the CSO attributes to the expiration of some contract sales deals. Article

> Amdescope, a CRO from Finland, announced that it would offer the PlexPress' TRAC (transcript analysis with the aid of affinity capture) platform for high-throughput gene expression analysis, as part of its in vitro drug interaction and preclinical ADME-Tox services. News

> Industry leaders gathered at the Avoca Group's Quality Summit this month in New Jersey, where they discussed how to ensure high-quality, outsourced clinical research. Story

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

WCG is continuing its buyout run after acquiring clinical trial solutions firm Trifecta Clinical.

London-based uMed has raised nearly $4.8 million from U.K. and U.S. VCs to help healthcare providers participate in more clinical studies.

Amgen has teamed up with cloud-based trial solutions firm Reify Health to help boost patients into its drug studies.